Fusion LC Method Development
Presentations / Articles / Application Notes
Presentations / Articles
Below are presentations & articles which describe the power and efficiency customers achieve using Fusion QbD.
S-Matrix Presentation — IFPAC 2024. Invited Speaker — Organized Session — Advanced Separations
Mapping Key Elements in the ICH Q14 and USP <1220> Guidances to an Enhanced Workflow for Analytical Procedure Development.
DOWNLOAD PDF»
Journal of Separation Science (J Sep Sci 2023; 46:2300520)
Controlling the elution order of insulin and its analogs in sub-/supercritical fluid chromatography using methanesulfonic acid and 18-crown-6 as mobile phase additives.
DOWNLOAD PDF»
S-Matrix Presentation — Pittcon 2023. Invited Speaker — Organized Session — Pharmaceutical
Impacts of USP Modernization Initiatives on Analytical Development for Drug Products.
DOWNLOAD PDF»
European Pharmaceutical Review (October 2022) Volume 27, Issue 05
Using design of experiments to optimise SEC method conditions for proteins.
DOWNLOAD PDF»
Journal of Pharmaceutical and Biomedical Analysis 205 (2021) 114306
Stability-indicating method development for quantification of bromopride, its impurities, and degradation products by ultra-high performance liquid chromatography applying Analytical Quality by Design principles.
VIEW ARTICLE»
Journal of Chromatography Science, 2021, 1–9
Ginsenoside Contents in Ginseng: Quality by Design-Coupled Two-Dimensional Liquid Chromatography Technique.
DOWNLOAD PDF»
Journal of Pharmaceutical and Biomedical Analysis
Ultra high-performance liquid chromatography method development for separation of formoterol, budesonide, and related substances using an analytical quality by design approach.
(Volume 193, 30 January 2021)
VIEW ARTICLE»
ACS Omega 2020
Development of a Stability-Indicating Analytical Method for Determination of Venetoclax Using AQbD Principles.
DOWNLOAD PDF»
American Chemical Society Spring 2020 Expo Presentation
Experimental design applied in UPLC-DAD method development of Malpighiaceae species extracts and metabolite identification.
DOWNLOAD PDF»
S-Matrix Presentation — EAS 2019
Successful Modernization of a USP Monograph Method using Fusion QBD Software resulted in an Optimized LC/MS Method and Eliminated the Need for a Separate GC Method.
DOWNLOAD PDF»
S-Matrix Presentation — EAS 2019
Integrating and Automating the Use of PDA and MS Data in LC and LC/MS Method Development.
DOWNLOAD PDF»
Chromatography Today Article
Integration of MS and UV Data for Peak Tracking in HPLC Method Development.
(February/March 2019 Issue)
DOWNLOAD PDF»
Journal of Separation Science Article
Ultra high performance liquid chromatography method development for separation of omeprazole and related substances on core‐shell columns using a Quality by Design approach.
[Modernization of the USP Monograph method for Omeprazole and related substances using Fusion QbD]
(November 2019 Issue)
VIEW ARTICLE»
Pharmaceutical Online Article
How To Use QbD Software To Improve An Existing Identification Method.
[Modernization of the USP Monograph method for Human serum albumin (HSA) using Fusion QbD]
(November 2017 Issue)
VIEW ARTICLE»
Chromicent GmbH Presentation — SFC Congress 2016
Development of an SFC Method for QC of Carbamazepine using Fusion QbD.
DOWNLOAD PDF»
Pfizer Presentation — HPLC 2016
Use of Fusion QbD for Automated Method Screening for Biotherapeutics.
DOWNLOAD PDF»
LCGC North America article
New HPLC Systems and Related Products (Volume 34, Number 4, April 2016, Chromatography Data Systems — Pages 271–272).
VIEW ARTICLE»
Chromatography Today article
Fusion QbD and the ‘Perfect Storm’ of Technologies Driving QbD-aligned LC Method Development (Published in the August / September 2015 issue of Chromatography Today).
DOWNLOAD PDF»
Journal of Chromatography A
Development and validation of a rapid ultra-high performance liquid chromatography method for the assay of benzalkonium chloride using a quality-by-design approach (Journal of Chromatography A, 1413 (2015) 22–32).
DOWNLOAD PDF»
FDA Presentation — IFPAC 2015
FDA-EMA Collaborative Research on Analytical QbD — Screening and Optimization Designs to Improve Method Performance and Robustness.
DOWNLOAD PDF»
Journal of Liquid Chromatography & Related Technologies
A QbD with Design-of-Experiments Approach for Development of a State-of-the-Art UPLC Purity Method for Carbamazepine.
VIEW ARTICLE
Journal of Pharmaceutical and Biomedical Analysis
Improved quality-by-design compliant methodology for method development in reversed-phase liquid chromatography.
VIEW ARTICLE
American Pharmaceutical Review article
Newer Developments in HPLC Impacting Pharmaceutical Analysis: A Brief Review. (Published in the May/June 2013 issue of American Pharmaceutical Review, Volume 16 Issue 4)
DOWNLOAD PDF»
Amgen Presentation — AAPS 2012
Evaluation of Fusion QbD system – A QbD Approach to Method Development and Robustness Studies (SEC-LC and CEX-LC).
DOWNLOAD PDF»
Boehringer Ingelheim Presentation — Pittcon 2012
QbD LC Method Development Using FMD Software.
DOWNLOAD PDF»
Journal of Chromatographic Science article
Quality by Design (QbD) Based Development of a Stability Indicating HPLC Method for Drug and Impurities.
DOWNLOAD PDF»
LCGC North America article
A Quality-by-Design Methodology for Rapid LC Method Development, Part III.
DOWNLOAD PDF»
Application Notes
Fusion LC Method Development has been in use for a number of years, and customers have successfully applied FMD to develop and optimize LC methods according to QbD guidelines for a wide variety of sample types, including small molecules, peptides, proteins, and nucleotides. Fusion QbD supports a wide range of chromatographic techniques for these samples, including reversed phase, normal phase, ion exchange, HILIC and Chiral separations, and it has never failed to identify an improved method which meets performance requirements.
Below are application notes which demonstrate the power and efficiency of Fusion QbD for chromatographic methods development.
Application Note 005-02
Development of a robust pH gradient method for mAb charge variant analysis using CIEX with Fusion QbD
DOWNLOAD PDF»
Application Note 005-01
Automated method optimization for drug-to-antibody ratio determination using HIC with Fusion QbD
DOWNLOAD PDF»
Application Note 004-07
Separation of a Critical Pair of N-Glycans using a Quality by Design (QbD) Approach.
DOWNLOAD PDF»
Application Note 004-06
Rapid Development and Validation of a Size Exclusion Chromatography Method Using Fusion QbD.
DOWNLOAD PDF»
Application Note 004-05
QbD Based Method Development — Agilent Infinity II UHPLC and ISET Operating Under Empower 3.
DOWNLOAD PDF»
Application Note 004-04
QbD Based Development of a Robust Peptide Mapping Method for a Therapeutic Monoclonal Antibody (mAb).
DOWNLOAD PDF»
Application Note 004-03
QbD Based UHPLC Method Development with Seamless Method Transfer to HPLC Using Intelligent System Emulation Technology
DOWNLOAD PDF»
Application Note 004-02
Automated QbD-Based Method Development and Validation of Oxidative Degraded Atorvastatin
DOWNLOAD PDF»
Application Note 004-01
A QbD Approach to Stability Indicating Method Development for Linagliptin Drug Product.
DOWNLOAD PDF»
Application Note 003-03
QbD Optimization of an Impurities Method using Peroxide Degraded Ziprasidone.
DOWNLOAD PDF»
Application Note 003-02
A QbD with Design-of-Experiments Approach to the Development of a Chromatographic Method for the Separation of Impurities in Vancomycin.
DOWNLOAD PDF»
Application Note 003-01
Accelerated, Automated Development of Robust LC Methods within a QbD Framework.
DOWNLOAD PDF»
Application Note 002-02
Using a Design of Experiments Approach to Develop Fast LC Methods for Automated Scale-up to Preparative Chromatography of Sulfa Drugs.
VIEW ARTICLE» DOWNLOAD PDF»
Application Note 002-01
Rapid development of an LC method for separating high molecular weight degradants from a biopharmaceutical product using an automated Design of Experiments (DOE) approach.
VIEW ARTICLE» DOWNLOAD PDF»
Application Note 001-01
DOE-based Study of Separation of Organic Acids using HILIC.
DOWNLOAD PDF»